The Difficulties in Emotional Regulation among a Cohort of Females with Lipedema.
anxiety
emotion regulation
lipedema
obesity
psychological disorders
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
21 10 2022
21 10 2022
Historique:
received:
02
08
2022
revised:
30
09
2022
accepted:
19
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Lipedema is a chronic and progressive adipose tissue disorder that causes significant morbidity and negatively influences mental health and quality of life, and increases the risk of depression, anxiety, and eating disorders. One construct of relevance to better understanding psychological disorders is emotion regulation (ER). Therefore, the aim of this study is to investigate the difficulties in ER among lipedema patients compared to healthy people without lipedema. This cross-sectional study assessed differences in ER and anxiety between two groups: 26 female patients with lipedema and 26 sex- and age-matched healthy controls. The Difficulties in Emotion Regulation Scale (DERS) assessed emotional regulation across six dimensions: Impulse control, goal-directed behavior, awareness, clarity, non-acceptance, and strategies. Anxiety was assessed by the Hamilton Anxiety Scale (HAM-A). ANOVA assessed differences in measures between lipedema and healthy control groups. Lipedema patients presented with significantly more difficulties in ER and a higher level of anxiety than those without lipedema. Specifically, the lipedema group showed higher and significant differences in total DERS and anxiety scores and all DERS subscales scores compared to those without lipedema. Lipedema patients showed significant difficulties with ER, and were associated with anxiety symptoms, indicating that ER difficulties may play a role in developing emotional disorders, such as anxiety, for patients with lipedema. The health care provider should pay more attention to ER difficulties and psychological status among lipedema patients.
Sections du résumé
BACKGROUND
Lipedema is a chronic and progressive adipose tissue disorder that causes significant morbidity and negatively influences mental health and quality of life, and increases the risk of depression, anxiety, and eating disorders. One construct of relevance to better understanding psychological disorders is emotion regulation (ER). Therefore, the aim of this study is to investigate the difficulties in ER among lipedema patients compared to healthy people without lipedema.
METHODS
This cross-sectional study assessed differences in ER and anxiety between two groups: 26 female patients with lipedema and 26 sex- and age-matched healthy controls. The Difficulties in Emotion Regulation Scale (DERS) assessed emotional regulation across six dimensions: Impulse control, goal-directed behavior, awareness, clarity, non-acceptance, and strategies. Anxiety was assessed by the Hamilton Anxiety Scale (HAM-A). ANOVA assessed differences in measures between lipedema and healthy control groups.
RESULTS
Lipedema patients presented with significantly more difficulties in ER and a higher level of anxiety than those without lipedema. Specifically, the lipedema group showed higher and significant differences in total DERS and anxiety scores and all DERS subscales scores compared to those without lipedema.
CONCLUSIONS
Lipedema patients showed significant difficulties with ER, and were associated with anxiety symptoms, indicating that ER difficulties may play a role in developing emotional disorders, such as anxiety, for patients with lipedema. The health care provider should pay more attention to ER difficulties and psychological status among lipedema patients.
Identifiants
pubmed: 36294260
pii: ijerph192013679
doi: 10.3390/ijerph192013679
pmc: PMC9602978
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Expert Rev Neurother. 2020 Apr;20(4):385-400
pubmed: 32196399
Ann Rehabil Med. 2011 Dec;35(6):922-7
pubmed: 22506222
Dermatol Ther (Heidelb). 2018 Jun;8(2):303-311
pubmed: 29748843
J Abnorm Child Psychol. 2018 Aug;46(6):1351-1358
pubmed: 29101588
Adv Skin Wound Care. 2010 Feb;23(2):81-92; quiz 93-4
pubmed: 20087075
Harv Rev Psychiatry. 2014 May-Jun;22(3):149-61
pubmed: 24704784
Health Care Women Int. 2022 Jan-Mar;43(1-3):54-69
pubmed: 34252343
J Youth Adolesc. 2017 Feb;46(2):261-276
pubmed: 27734198
Qual Life Res. 2022 Aug 16;:
pubmed: 35972618
Addict Behav. 2008 Feb;33(2):388-94
pubmed: 18023295
Cogn Emot. 2010 Feb 1;24(2):281-98
pubmed: 20300538
Cognit Ther Res. 2016 Jun;40(30):328-340
pubmed: 27231404
Horm Mol Biol Clin Investig. 2021 Jul 29;42(4):351-355
pubmed: 34323062
Monogr Soc Res Child Dev. 1994;59(2-3):73-100
pubmed: 7984169
Addict Behav. 2018 Dec;87:200-205
pubmed: 30053706
Curr Opin Psychol. 2015 Jun 1;3:85-90
pubmed: 25859561
Eur Eat Disord Rev. 2018 Jan;26(1):38-45
pubmed: 29067753
Eat Weight Disord. 2019 Aug;24(4):633-644
pubmed: 31243741
J Pain Res. 2018 Oct 02;11:2145-2159
pubmed: 30323649
Obes Rev. 2018 Jan;19(1):111-120
pubmed: 29024361
Appetite. 2012 Aug;59(1):21-6
pubmed: 22425760
J Youth Adolesc. 2012 Dec;41(12):1628-42
pubmed: 22739935
Clin Psychol Rev. 2017 Nov;57:141-163
pubmed: 28941927
Br J Dermatol. 2009 Nov;161(5):980-6
pubmed: 19785610
J Psychosom Res. 2004 Jul;57(1):35-43
pubmed: 15256293
Qual Life Res. 2020 Feb;29(2):431-438
pubmed: 31605308
Clin Obes. 2020 Oct;10(5):e12388
pubmed: 32633060
Psychol Health Med. 2018 Aug;23(7):846-853
pubmed: 29614880
Eat Weight Disord. 2020 Aug;25(4):851-856
pubmed: 31062201
Acta Pharmacol Sin. 2012 Feb;33(2):155-72
pubmed: 22301856
J Clin Psychol. 2012 Sep;68(9):989-1007
pubmed: 22653763
J Anxiety Disord. 2008;22(2):199-210
pubmed: 17419002
Narrat Inq Bioeth. 2014 Summer;4(2):E6-9
pubmed: 25130361
Appetite. 2014 Feb;73:45-50
pubmed: 24511618